Clinical trial
Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
NCT01762046 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study to Understand the Genetics of the Acute Response to Metformin and Glipizide in Humans
- Lead sponsor
- Massachusetts General Hospital
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- January 31, 2008
- Completion date
- December 31, 2025
- Enrollment
- 1,033 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.